The Director, US Real World Evidence & Health Outcomes (US RWE/HO), Anti-infectives and Respiratory, reports to US RWE/HO Therapeutic Area Head, Anti-Infectives & Respiratory. The incumbent will provide leadership in developing and executing a quality, strategically aligned research agenda, focused on delivering a relevant, high impact evidence package to demonstrate the value of US pipeline and marketed assets in the assigned therapeutic area. They will conduct research that incorporates customer insights from the US reimbursement and access environment to support the strategic direction of the asset & work closely with the field-based medical and payer teams to obtain US physician, reimbursement and access insights. The Director will represent US RWE/HO on matrix teams and advise internal stakeholders in clinical development, payer marketing and commercial; ensure provision of US RWE/HO information to support internal decision-making during product development and commercialization. They will fully integrate with evidence generation partners (Global RWE/HO, Epidemiology and other quantitative sciences) and develop a framework for aligning evidence generation activities across the matrix facilitating delivery of a value evidence package. They will manage budgets for multiple US-focused projects and/or product budgets and be responsible for governance-related activities for projects and represent the department at a disease and product level at external professional, scientific meetings and forums. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Industry
Chemical Manufacturing
Number of Employees
5,001-10,000 employees